Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jbc.2024.107975 | DOI Listing |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11648214 | PMC |
Newborn (Clarksville)
March 2024
Global Newborn Society, Clarksville Maryland, United States of America.
Clin Nutr
November 2024
Channing Division of Network Medicine, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, USA; Division of Renal Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, USA. Electronic address:
Background & Aims: Although vitamin D deficiency is common in critically ill patients, randomized controlled trials fail to demonstrate benefits of supplementation. We aimed to identify distinct vitamin D responsive metabolic phenotypes prior to trial intervention of high-dose vitamin D by applying machine learning clustering method to metabolomics data from the Correction of Vitamin D Deficiency in Critically Ill Patients (VITdAL-ICU) trial.
Methods: In the randomized, placebo-controlled VITdAL-ICU trial, critically ill adults received placebo or high-dose vitamin D.
Front Immunol
September 2024
Department of Cardiology, Lihuili Hospital Affiliated to Ningbo University, Ningbo University, Ningbo, Zhejiang, China.
Biomolecules
March 2024
Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.
The severity of COVID-19 is linked to an imbalanced immune response. The dysregulated metabolism of small molecules and bioactive lipids has also been associated with disease severity. To promote understanding of the disease biochemistry and provide targets for intervention, we applied a range of LC-MS platforms to analyze over 100 plasma samples from patients with varying COVID-19 severity and with detailed clinical information on inflammatory responses (>30 immune markers).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!